Factor VII

Coagulation factor VII (serum prothrombin conversion accelerator)

Anchoring of coagulation factor VIIa to the membrane through its Gla domain
Identifiers
Symbols F7;
External IDs OMIM613878 MGI109325 HomoloGene7710 GeneCards: F7 Gene
EC number 3.4.21.21
RNA expression pattern
PBB GE F7 207300 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 2155 14068
Ensembl ENSG00000057593 ENSMUSG00000031443
UniProt P08709 Q542C2
RefSeq (mRNA) NM_000131.3 NM_010172.3
RefSeq (protein) NP_000122.1 NP_034302.2
Location (UCSC) Chr 13:
113.76 – 113.77 Mb
Chr 8:
13.03 – 13.04 Mb
PubMed search [1] [2]

Factor VII (formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme (EC 3.4.21.21) of the serine protease class. A recombinant form of human factor VIIa (NovoSeven, eptacog alfa [activated]) has U.S. Food and Drug Administration approval for uncontrolled bleeding in hemophilia patients. It is often used unlicensed in severe uncontrollable bleeding, although there has been safety concerns.

Contents

Physiology

The main role of factor VII (FVII) is to initiate the process of coagulation in conjunction with tissue factor (TF/factor III). Tissue factor is found on the outside of blood vessels - normally not exposed to the bloodstream. Upon vessel injury, tissue factor is exposed to the blood and circulating factor VII. Once bound to TF, FVII is activated to FVIIa by different proteases, among which are thrombin (factor IIa), factor Xa, IXa, XIIa, and the FVIIa-TF complex itself. The most important substrates for FVIIa-TF are Factor X and Factor IX.

The action of the factor is impeded by tissue factor pathway inhibitor (TFPI), which is released almost immediately after initiation of coagulation. Factor VII is vitamin K dependent; it is produced in the liver. Use of warfarin or similar anticoagulants decreases hepatic synthesis of FVII.

Genetics

The gene for factor VII is located on chromosome 13 (13q34).

Role in disease

Deficiency is rare (congenital proconvertin deficiency) and inherits recessively. Factor VII deficiency presents as a hemophilia-like bleeding disorder. It is treated with recombinant factor VIIa (NovoSeven).

Therapeutic use

Recombinant human factor VIIa (NovoSeven, eptacog alfa [activated], ATC code B02BD08) has been introduced for use in uncontrollable bleeding in hemophilia patients (with Factor VIII or IX deficiency) who have developed inhibitors against replacement coagulation factor.

It is being increasingly used in uncontrollable hemorrhage.[1] The first report of its use was in an Israeli soldier with uncontrollable bleeding in 1999.[2] The rationale for its use in hemorrhage is, that it will only induce coagulation in those sites where tissue factor (TF) is also present. Still, O'Connell et al. report an increased risk of deep vein thrombosis, pulmonary embolism and myocardial infarction in association with the use of rhFVIIa.[3] A 2008 meta-analysis of randomized controlled trials of of rhFVIIa in patients without hemophilia showed no additional risk of deep vein thrombosis or pulmonary embolism and the risk of arterial thrombosis to be substantially less than the potential to reduce mortality.[4] In 2010 a larger study combining the results 35 trials showed a definite increase in arterial thrombosis, the risk of which was higher in older patients.[5]

According to a 2005 study, recombinant human factor VII improves outcomes in acute intracerebral hemorrhage.,[6] but a more recent, larger 2008 study by the same group to address these initial findings failed to show any mortality benefit. Factor VII is no longer recommended in the treatment of patients with intracerebral hemorrhage.[7]

Interactions

Factor VII has been shown to interact with Tissue factor.[8][9]

References

  1. ^ Roberts H, Monroe D, White G (2004). "The use of recombinant factor VIIa in the treatment of bleeding disorders". Blood 104 (13): 3858–64. doi:10.1182/blood-2004-06-2223. PMID 15328151. 
  2. ^ Kenet G, Walden R, Eldad A, Martinowitz U (1999). "Treatment of traumatic bleeding with recombinant factor VIIa". Lancet 354 (9193): 1879. doi:10.1016/S0140-6736(99)05155-7. PMID 10584732. 
  3. ^ O'Connell K, Wood J, Wise R, Lozier J, Braun M (2006). "Thromboembolic adverse events after use of recombinant human coagulation factor VIIa". JAMA 295 (3): 293–8. doi:10.1001/jama.295.3.293. PMID 16418464. 
  4. ^ Hsia CC, Chin-Yee IH, McAlister VC (July 2008). "Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials". Ann. Surg. 248 (1): 61–8. doi:10.1097/SLA.0b013e318176c4ec. PMID 18580208. 
  5. ^ Levi M, Levy JH, Andersen HF, Truloff D (November 2010). "Safety of recombinant activated factor VII in randomized clinical trials". N. Engl. J. Med. 363 (19): 1791–800. doi:10.1056/NEJMoa1006221. PMID 21047223. 
  6. ^ Mayer S, Brun N, Begtrup K, Broderick J, Davis S, Diringer M, Skolnick B, Steiner T (2005). "Recombinant activated factor VII for acute intracerebral hemorrhage". N. Engl. J. Med. 352 (8): 777–85. doi:10.1056/NEJMoa042991. PMID 15728810. 
  7. ^ Mayer SA, Brun NC, Begtrup K, et al. (May 2008). "Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage". N. Engl. J. Med. 358 (20): 2127–37. doi:10.1056/NEJMoa0707534. PMID 18480205. http://www.nejm.org/doi/full/10.1056/NEJMoa0707534. 
  8. ^ Carlsson, Karin; Freskgård Per-Ola, Persson Egon, Carlsson Uno, Svensson Magdalena (Jun. 2003). "Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor". Eur. J. Biochem. (Germany) 270 (12): 2576–82. doi:10.1046/j.1432-1033.2003.03625.x. ISSN 0014-2956. PMID 12787023. 
  9. ^ Zhang, E; St Charles R, Tulinsky A (Feb. 1999). "Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant". J. Mol. Biol. (ENGLAND) 285 (5): 2089–104. doi:10.1006/jmbi.1998.2452. ISSN 0022-2836. PMID 9925787. 

External links

Further reading

  • Broze GJ Jr, Majerus PW (1980). "Purification and properties of human coagulation factor VII". J. Biol. Chem. 255 (4): 1242–7. PMID 7354023. 
  • Versteeg HH, Peppelenbosch MP, Spek CA (2002). "The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?". Thromb. Haemost. 86 (6): 1353–9. PMID 11776298. 
  • Golino P (2003). "The inhibitors of the tissue factor:factor VII pathway". Thromb. Res. 106 (3): V257–65. doi:10.1016/S0049-3848(02)00079-8. PMID 12356487. 

Wikimedia Foundation. 2010.

Look at other dictionaries:

  • factor VII — sev ən, seb əm n a clotting factor in normal blood that is formed in the kidney under the influence of vitamin K and may be deficient due to a hereditary disorder or to a vitamin K deficiency called also autoprothrombin I, cothromboplastin,… …   Medical dictionary

  • factor VII — Procoagulante sanguíneo presente en el plasma que se sintetiza en el hígado en presencia de vitamina K. Diccionario Mosby Medicina, Enfermería y Ciencias de la Salud, Ediciones Hancourt, S.A. 1999 …   Diccionario médico

  • factor VII — noun a coagulation factor formed in the kidney under the influence of vitamin K • Syn: ↑proconvertin, ↑cothromboplastin, ↑stable factor • Hypernyms: ↑coagulation factor, ↑clotting factor …   Useful english dictionary

  • Factor VII — Proconvertina (también SPCA, Factor estable, Acelerador de conversión de protrombina sérica o Autoprotrombina I) …   Diccionario de siglas médicas y otras abreviaturas

  • Factor VII-activating protease — Faktor VII aktivierende Protease Größe 537 = 290+247 Aminosäuren Struktur Heterodimer Bezeichner …   Deutsch Wikipedia

  • Factor tisular — 100px Factor de coagulación III (factor tisular de tromboplastina) Identificadores Símbolo F3 Pfam …   Wikipedia Español

  • Factor de coagulación — Saltar a navegación, búsqueda Los factores de coagulación son todas aquellas proteínas originales de la sangre que participan y forman parte del coágulo sanguíneo. Son trece los factores de coagulación, nombrados con números romanos, todos ellos… …   Wikipedia Español

  • factor de coagulación — m. hemat. Cada una de las 13 sustancias necesarias para la formación de la fibrina y cuya acción conjunta es la responsable del proceso de coagulación de la sangre. Medical Dictionary. 2011. factor de coagulación …   Diccionario médico

  • Factor estable — Factor VII de la coagulación …   Diccionario de siglas médicas y otras abreviaturas

  • Factor X — For other uses, see Factor X (disambiguation). Coagulation factor X PDB rendering based on 1c5m …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.